Author | Beth Fand Incollingo


Addition to avelumab to best supportive care after firstline chemo improves OS in advanced urothelial Ca

June 03, 2020

Avelumab (Bavencio) as a maintenance treatment after chemotherapy significantly extended overall survival in patients with advanced urothelial cancer, according to findings from thephase III JAVELIN Bladder 100 trial.